Merck & Co New: (NYSE: MRK)
$47.58
-0.17 (-0.36%)
Volume 17,936,496
04:00 PM ET
Zacks Rank: 3-Hold 
BROKERAGE REPORTS
0 items in cart
MERCK & CO INC [MRK]
Reports for Purchase
Showing records 1 - 20 ( 43 total )
|
Price: 24.95
|
|
Price: 24.95
|
|
Price: 24.95
|
|
Company: MERCK & CO INC Industry: LARGE CAP PHARMA Fourth Quarter Revenue Impacted by a Full Quarter of Generic Competition for Singulair Provider: J.J.B. Hilliard, W.L. Lyons Analyst: O'NEIL S
Price: 25.00 |
|
Price: 24.95
|
|
Company: MERCK & CO INC Industry: LARGE CAP PHARMA Third Quarter Reflected the Singulair Patent Expiration Provider: J.J.B. Hilliard, W.L. Lyons Analyst: O'NEIL S
Price: 25.00 |
|
Price: 24.95
|
|
Price: 24.95
|
|
Company: MERCK & CO INC Industry: LARGE CAP PHARMA Double-Digit 2Q EPS Growth Beat Expectations Provider: J.J.B. Hilliard, W.L. Lyons Analyst: O'NEIL S
Price: 25.00 |
|
Price: 24.95
|
|
Company: MERCK & CO INC Industry: LARGE CAP PHARMA Griffin Securities Updates Coverage on Ligand Pharma. (LGND) Provider: GRIFFIN SECURITIES, INC. Analyst: MARKEY K
Price: 75.00 |
|
Price: 24.95
|
|
Price: 24.95
|
|
Company: MERCK & CO INC Industry: LARGE CAP PHARMA No Surprises in First Quarter Results Provider: J.J.B. Hilliard, W.L. Lyons Analyst: O'NEIL S
Price: 25.00 |
|
Price: 24.95
|
|
Company: MERCK & CO INC Industry: LARGE CAP PHARMA Company Leveraged 2% Fourth Quarter Sales Growth into a Double-Digit Earnings Gain Provider: J.J.B. Hilliard, W.L. Lyons Analyst: O'NEIL S
Price: 25.00 |
|
Price: 24.95
|
|
Price: 24.95
|
|
Company: MERCK & CO INC Industry: LARGE CAP PHARMA Broad-based Worldwide Third Quarter Revenue Growth Provider: J.J.B. Hilliard, W.L. Lyons Analyst: O'NEIL S
Price: 25.00 |
|
Price: 24.95
|
